| Vicki A Deshazo, | |
|
208 Bellevue Way Ne, Bellevue, WA 98004-5720 | |
| (425) 455-5596 | |
| (425) 451-3248 |
| Full Name | Vicki A Deshazo |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 208 Bellevue Way Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811940349 | NPI | - | NPPES |
| 1092881 | Medicaid | WA | |
| 8450512 | Other | WA | MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | LD00002762 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vicki A Deshazo, 208 Bellevue Way Ne, Bellevue, WA 98004-5720 Ph: (425) 455-5596 | Vicki A Deshazo, 208 Bellevue Way Ne, Bellevue, WA 98004-5720 Ph: (425) 455-5596 |
News Archive
In a recent study published in the Journal of Trauma and Acute Care Surgery, researchers from the Center for Injury Research and Policy in The Research Institute at Nationwide Children's Hospital found that pediatric trauma patients with preexisting chronic conditions have longer hospital stays, higher hospital charges and an increased mortality risk.
AvidBiotics Corp. announced the issuance of foundational patents encompassing a completely novel mechanism for generating massive diversity within precisely targeted sites of protein-encoding DNA sequences. The technology platform is referred to as Diversity Generating Retroelements (DGR) and patents were issued in both the United States (#7,585,957) and in Europe (#1,173,995). UCLA and AvidBiotics Corp are co-assignees of the patents, and AvidBiotics holds exclusive, worldwide rights to the patents from UCLA.
New preliminary data from the United States Centers for Disease Control and Prevention (CDC) suggests that average life expectancy in the United States fell by 1.5 years over 2020.
​Dabrafenib (trade name: Tafinlar) has been approved since August 2013 for the treatment of advanced melanoma. In January 2014, in an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) had determined that dabrafenib has no added benefit in comparison with dacarbazine.
› Verified 8 days ago
Marcy Hannah Abong, Audiologist Medicare: Medicare Enrolled Practice Location: 1370 116th Ave Ne Ste 201, Bellevue, WA 98004 Phone: 425-455-0526 | |
David A Renne, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1038 116th Ave Ne, Ste 330, Bellevue, WA 98004 Phone: 425-455-5596 Fax: 425-451-3248 | |
Dr. Kaitlyn Elizabeth Gervais, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1940 116th Ave Ne Ste 103, Bellevue, WA 98004 Phone: 800-500-8243 Fax: 253-759-2988 | |
Mrs. Sonia Sunhee Choi, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3490 | |
Jo Koenig Hall, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1135 116th Ave Ne, Suite 400, Bellevue, WA 98004 Phone: 206-987-5770 Fax: 206-987-5779 | |
Mrs. Corina Dawn Peterson, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne, Suite 915, Bellevue, WA 98004 Phone: 425-454-3938 Fax: 425-454-2568 | |
Kate B Jablonski, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1038 116th Ave Ne, Ste 330, Bellevue, WA 98004 Phone: 425-455-5596 Fax: 425-451-3248 |